
|Videos|November 15, 2020
AAO 2020: Medication could reduce burden of steroid drops for patients
Author(s)OT Staff Reports
Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5




















